Increase of plasminogen activator inhibitor-1 and decrease of transforming growth factor-β1 in children with dengue haemorrhagic fever in Indonesia

Journal of Tropical Pediatrics

Volumn 57, Issue 6, 2011, Pages 424-432

  Djamiatun, Kis ^a   Faradz, Sultana M H ^a   Setiati, Tatty E ^a   Netea, Mihai G ^b   van der Ven, Andre J A M ^b   Dolmans, Wil M V ^b  

^a DIPONEGORO UNIVERSITY   (Indonesia)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Dengue; Pai 1; Plasma leakage; TGF 1

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ASPARTATE AMINOTRANSFERASE; PLASMINOGEN ACTIVATOR INHIBITOR 1; TRANSFORMING GROWTH FACTOR BETA1;

ADOLESCENT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CHILD; CHILDHOOD DISEASE; CONTROLLED STUDY; DENGUE; FEMALE; HOSPITAL ADMISSION; HUMAN; INDONESIA; MAJOR CLINICAL STUDY; MALE; PLASMA LEAKAGE; PLEURA EFFUSION; PRESCHOOL CHILD; PROTEIN BLOOD LEVEL; SCHOOL CHILD; THROMBOCYTE COUNT; VASCULAR DISEASE;

ADOLESCENT; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; DENGUE HEMORRHAGIC FEVER; FEMALE; HUMANS; INDONESIA; LIVER FUNCTION TESTS; MALE; PLASMINOGEN ACTIVATOR INHIBITOR 1; PLATELET COUNT; PLEURAL EFFUSION; SERUM ALBUMIN; TRANSFORMING GROWTH FACTOR BETA1;

EID: 82955173083     PISSN: 01426338     EISSN: 14653664     Source Type: Journal    
DOI: 10.1093/tropej/fmq122     Document Type: Article

References (35)

1. Rigau-Perez JG, Clark GG, Gubler DJ, et al. Dengue and dengue haemorrhagic fever. Lancet 1998;352: 971-7.
2. WHO. Dengue Haemorrhagic Fever: Diagnosis, Treatment, Prevention and Control. Vol. 2nd edn. Geneva: World Health Organization, 1997.
3. Srichaikul T, Nimmannitya S. Haematology in dengue and dengue haemorrhagic fever. Baillieres Best Pract Res Clin Haematol 2000;13:261-76.
4. Van Gorp EC, Setiati TE, Mairuhu AT, et al. Impaired fibrinolysis in the pathogenesis of dengue hemorrhagic fever. J Med Virol 2002;67:549-54.
5. Wills BA, Oragui EE, Stephens AC, et al. Coagulation abnormalities in dengue hemorrhagic fever: serial investigations in 167 Vietnamese children with dengue shock syndrome. Clin Infect Dis 2002;35:277-85.
6. Hermans PW, Hibberd ML, Booy R, et al. 4G/5G promoter polymorphism in the plasminogen-activator-inhibitor-1 gene and outcome of meningococcal disease. Meningococcal Research Group. Lancet 1999;354: 556-60.
7. Westendorp RG, Hottenga JJ, Slagboom PE. Variation in plasminogen-activator-inhibitor-1 gene and risk of meningococcal septic shock. Lancet 1999; 354:561-3.
8. Mairuhu AT, Setiati TE, Koraka P, et al. Increased PAI-1 plasma levels and risk of death from dengue: no association with the 4G/5G promoter polymorphism. Thromb J 2005;3:17.
9. Pihusch V, Pihusch M, Penovici M, et al. Transforming growth factor beta-1 released from platelets contributes to hypercoagulability in veno-occlusive disease following hematopoetic stem cell transplantation. Thromb Res 2005;116:233-40.
10. Agarwal R, Elbishbishi EA, Chaturvedi UC, et al. Profile of transforming growth factor-beta 1 in patients with dengue haemorrhagic fever. Int J Exp Pathol 1999; 80:143-9.
11. Laur F, Murgue B, Deparis X, et al. Plasma levels of tumour necrosis factor alpha and transforming growth factor beta-1 in children with dengue 2 virus infection in French Polynesia. Trans R Soc Trop Med Hyg 1998;92: 654-6.
12. Assoian RK, Komoriya A, Meyers CA, et al. Transforming growth factor-beta in human platelets. Identification of a major storage site, purification, and characterization. J Biol Chem 1983;258:715-1560.
13. Brogren H, Karlsson L, Andersson M, et al. Platelets synthesize large amounts of active plasminogen activator inhibitor 1. Blood 2004;104:3943-8.
14. Nishimura N, Harada-Shiba M, Tajima S, et al. Acquisition of secretion of transforming growth factor-beta 1 leads to autonomous suppression of scavenger receptor activity in a monocyte-macrophage cell line, THP-1. J Biol Chem 1998;273:1562-7.
15. Grotendorst GR, Smale G, Pencev D. Production of transforming growth factor beta by human peripheral blood monocytes and neutrophils. J Cell Physiol 1989; 140:396-402.
16. Assoian RK, Fleurdelys BE, Stevenson HC, et al. Expression and secretion of type beta transforming growth factor by activated human macrophages. Proc Natl Acad Sci USA 1987;84:6020-4.
17. Pannekoek H, Veerman H, Lambers H, et al. Endothelial plasminogen activator inhibitor (PAI): a new member of the Serpin gene family. EMBO J 1986;5:2539-44.
18. Schalkwijk CG, Ter Wee PM, Stehouwer CD. Plasma levels of AGE peptides in type 1 diabetic patients are associated with serum creatinine and not with albumin excretion rate: possible role of AGE peptide-associated endothelial dysfunction. Ann N Y Acad Sci 2005;1043: 662-70.
19. Wing LR, Hawksworth GM, Bennett B, Booth NA. Clearance of t-PA, PAI-1, and t-PA-PAI-1 complex in an isolated perfused rat liver system. J Lab Clin Med 1991;117:109-14.
20. Hayashi T, Kamogawa A, Ro S, et al. Plasma from patients with cirrhosis increases tissue plasminogen activator release from vascular endothelial cells in vitro. Liver 1998;18:186-90.
21. Tran-Thang C, Fasel-Felley J, Pralong G, et al. Plasminogen activators and plasminogen activator inhibitors in liver deficiencies caused by chronic alcoholism or infectious hepatitis. Thromb Haemost 1989; 62:651-3.
22. Binder BR, Christ G, Gruber F, et al. Plasminogen activator inhibitor 1: physiological and pathophysiological roles. News Physiol Sci 2002;17:56-61.
23. Mohan B, Patwari AK, Anand VK. Hepatic dysfunction in childhood dengue infection. J Trop Pediatr 2000; 46:40-3.
24. Pancharoen C, Rungsarannont A, Thisyakorn U. Hepatic dysfunction in dengue patients with various severity. J Med Assoc Thai 2002;85(Suppl. 1):S298-301.
25. Souza LJ, Alves JG, Nogueira RM, et al. Aminotransferase changes and acute hepatitis in patients with dengue fever: analysis of 1,585 cases. Braz J Infect Dis 2004;8:156-63.
26. Grainger DJ, Mosedale DE, Metcalfe JC. TGF-beta in blood: a complex problem. Cytokine Growth Factor Rev 2000;11:133-45.
27. Wakefield LM, Letterio JJ, Chen T, et al. Transforming growth factor-beta1 circulates in normal human plasma and is unchanged in advanced metastatic breast cancer. Clin Cancer Res 1995;1:129-36.
28. Kropf J, Schurek JO, Wollner A, et al. Immunological measurement of transforming growth factor-beta 1 (TGF-beta1) in blood; assay development and comparison. Clin Chem 1997;43:1965-74.
29. Grainger DJ, Wakefield L, Bethell HW, et al. Release and activation of platelet latent TGF-beta in blood clots during dissolution with plasmin. Nat Med 1995; 1:932-7.
30. Zhang G, Han J, Welch EJ, et al. Lipopolysaccharide stimulates platelet secretion and potentiates platelet aggregation via TLR4/MyD88 and the cGMP-dependent protein kinase pathway. J Immunol 2009;182: 7997-8004.
31. Grainger DJ, Heathcote K, Chiano M, et al. Genetic control of the circulating concentration of transforming growth factor type beta1. Hum Mol Genet 1999;8: 93-7.
32. Chen RF, Wang L, Cheng JT, et al. Combination of CTLA-4 and TGFbeta1 gene polymorphisms associated with dengue hemorrhagic fever and virus load in a dengue-2 outbreak. Clin Immunol 2009;131: 404-9.
33. van Deuren M, van der Ven-Jongekrijg J, Demacker PN, et al. Differential expression of proinflammatory cytokines and their inhibitors during the course of meningococcal infections. J Infect Dis 1994; 169:157-61.
34. Ghosh K, Gangodkar S, Jain P, et al. Imaging the interaction between dengue 2 virus and human blood platelets using atomic force and electron microscopy. J Electron Microsc 2008;57:113-18.
35. Wills BA, Oragui EE, Dung NM, et al. Size and charge characteristics of the protein leak in dengue shock syndrome. J Infect Dis 2004;190:810-18.